Page: Hantavirus-2026/5/22

Document: Scientific advice and protocol assistance adopted during the CHMP meeting 20-23 April 2026-2026/5/21

Document: List of eligible industry stakeholder organisations-2026/5/21

Page: Website outages and upgrades-2026/5/21

Document: Guidance on the details of the classification of variations requiring assessment according to Article 62 of Regulation (EU) 2019/6 for veterinary medicinal products and on the documentation to be submitted pursuant to those variations-2026/5/21

Page: Data Analysis and Real World Interrogation Network (DARWIN EU)-2026/5/20

Document: HMPC meeting report on European Union herbal monographs, guidelines and other activities - 4-6 May 2026-2026/5/20

Page: Clinical trials in human medicines-2026/5/20

Page: Product-specific bioequivalence guidance-2026/5/19

Document: Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (27 March 2026 - 23 April 2026)-2026/5/19